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Background: Although conventional (CAG) and computed tomography angiography (CTA) are reliable
diagnostic modalities for exclusion of obstructive coronary artery disease (CAD), they are costly and with
considerable exposure to radiation and contrast media. We compared the accuracy of coronary calcium
scanning (CCS) and exercise electrocardiography (X-ECG) as less expensive and non-invasive means to rule
out obstructive CAD.
Methods: In a rapid-access chest pain clinic, 791 consecutive patients with stable chest pain were planned to
undergo X-ECG and dual-source CTA with CCS. According to the Duke pre-test probability of CAD patients
were classiﬁed as low (b30%), intermediate (30–70%) or high risk (N70%). Angiographic obstructive CAD
(N50% stenosis by CAG or CTA) was found in 210/791 (27%) patients, CAG overruling any CTA results.
Results: Obstructive CAD was found in 12/281 (4%) patients with no coronary calcium and in 73/319 (23%)
with a normal X-ECG (pb0.001). No coronary calcium was associated with a substantially lower likelihood
ratio compared to X-ECG; 0.11, 0.13 and 0.13 vs. 0.93, 0.55 and 0.46 in the low, intermediate and high risk
group. In low risk patients a negative calcium score reduced the likelihood of obstructive CAD to less than 5%,
removing the need for further diagnostic work-up. CCS could be performed in 754/756 (100%) patients, while
X-ECG was diagnostic in 448/756 (59%) patients (pb0.001).
Conclusions: In real-world patients with stable chest pain CCS is a reliable initial test to rule out obstructive
CAD and can be performed in virtually all patients.
© 2011 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Angina pectoris is a common and disabling condition that affects
millions of people worldwide. The diagnostic evaluation and
subsequent management of patients suspected of coronary artery
disease (CAD) is aimed at reducing complaints and improving
prognosis. Although invasive coronary angiography (CAG) remains
the gold standard for the diagnosis of obstructive CAD, coronary
computed tomography (CTA) has emerged as a reliable non-invasive
alternative, with an excellent accuracy for ruling out obstructive CAD
[1–4]. However increasing concern about the costs, radiation
exposure and contrast agents involved with either angiographic
modalities justiﬁes exploration of alternative approaches [5–8].
Exercise electrocardiography (X-ECG) is a widely available, well-
established and cost-effective means to assess ischemic heart disease,
despite its limited diagnostic accuracy and substantial rate of
inconclusive test results [9]. Alternatively, coronary calcium scanningbox 2040, 3000 CA Rotterdam,
35482.
r the Elsevier OA license.(CCS) is inexpensive, fast, operator-independent, associated with a
much lower radiation exposure and without need for contrast media
[10,11].
In this studywe compared the ability of CCS and X-ECG as an initial
test to rule out obstructive CAD in a large group of patients with stable
angina from a rapid-access chest pain clinic. According to pre-test
probabilities of obstructive CAD patients were assigned to low,
intermediate and high risk groups.
2. Methods
2.1. Study population
From September 2006 to April 2010 we evaluated 791 consecutive patients with
stable chest complaints and no history of CAD at our rapid-access chest pain clinic.
Patients were planned to undergo both dual-source CTA and X-ECG, in addition to a
clinical examination and blood analysis. Referral to CAG was clinically driven.
Using the Duke Clinical Score (DCS), based on the type of chest discomfort, age,
gender and cardiovascular risk factors, patients were classiﬁed as having a low (b30%),
intermediate (30–70%) or high (N70%) pre-test probability of obstructive CAD [12].
Chest pain was classiﬁed using the three categories by Diamond: typical angina
pectoris, atypical angina pectoris and non-anginal chest pain [13].
Angiographic obstructive CAD was found in 210/791 (27%) patients, deﬁned as the
presence of N50% stenosis in≥1 coronary branches by CAG or CTA (CAG overruling any
Table 2
Scan parameters.
64-slice DSCTa 128-slice DSCTb
Patients (n) 527 234
Conventional spiral mode (n) 527 35
Sequential mode (n) 0 169
High pitch spiral mode (n) 0 30
Collimation (mm)c 64(32×2) 128(64×2)
Gantry rotation time (ms) 0.33 0.28
Effective temporal resolution (ms)d 83 75
Pitch (conventional spiral mode) 0.2–0.53 0.2–3
Tube voltage (kV) 120 100–120
Tube current (ma)e 370–412 320–412
Scan parameters of patients undergone CTA (761/791) using dual source computed
tomography (DSCT): Siemens Deﬁnitiona and Flashb, Forchheim, Germany; cby
alternating focal spot (Z-sharp®), dusing a single-segmental reconstruction
algorithm, edepending on patient size.
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b50% coronary stenosis by CAG (overruling any CTA result) or CTA.
In total 27/791 (3%) patients, without sufﬁcient cause for invasive angiography, did
not undergo CTA, because of renal failure, contrast allergy, patient preference,
Parkinson disease, patient willingness to cooperate, failed venous access and severe
obesity. Because of premature scan initiation or movement during scan 8 (1%) scans
were considered non-diagnostic.
The mean age in the study population was 56±10 years, with signiﬁcantly more
elderly patients in higher risk groups. Males were at higher risk for obstructive CAD,
although overall the gender was evenly divided (369/756=49% female) (Table 1).
There were fewer smokers, diabetics and patients with dyslipidemia in the low risk
group. There were more patients with hypertension and a history of vascular disease in
the high risk group.
The study complied with the Declaration of Helsinki and the ethical committee at
our institution approved the study. Informed consent was obtained from all patients.
2.2. Non-enhanced coronary calcium scan
The calcium scan was performed using an ECG-triggered sequential scan mode,
with 120-kV tube voltage, 78±26-mAs tube current and 3-mm slice thickness.
Quantiﬁcation was performed by the Agatston method with a standard 130-HU
attenuation threshold. The absence of detectable calcium was considered as a negative
CCS result. Patients with detectable coronary calcium were divided in two groups:
moderate (1–400) and severe (N400 Agatston units) [14,15].
2.3. Contrast-enhanced CT angiography
Computed tomography angiography was performed in the absence of the following
contraindications: pregnancy, renal dysfunction or known allergy to iodine contrast
media.
Image acquisition was conducted using a dual-source CT: Siemens Deﬁnition
(Forchheim, Germany) from September 2006 to April 2009 and Siemens Flash from
April 2009 to April 2010. Technical details regarding image acquisition are summarized
in Table 2. Before the scan patients received a sublingual dose of nitro-glycerine but no
additional beta-blockers.
Effective radiation doses for CCS and CTA were 0.8±0.2 mSv (range 0.4 to 1.6) and
8.5±3.4 mSv (range 0.5 to 17.8).
Readers were blinded for patients' symptoms or exercise test results. Data was sent
to an ofﬂine workstation for image analysis. All coronary segments were evaluated on
axial images, multiplanar reformations, and maximum intensity projections according
to readers' preferences. In a joint session, two readers evaluated the coronary anatomy,
and vessels were qualitatively scored as normal, not signiﬁcantly stenosed (b50%
stenosis) or signiﬁcantly stenosed (N50% stenosis).
2.4. Exercise electrocardiography
Bicycle X-ECG was performed by standardized protocol, with established criteria
for performance and exercise discontinuation. Criteria for myocardial ischemia
included horizontal or down sloping ST-segment depression or elevation ≥0.1 mV
during or after exercise or typical, increasing angina during exercise. In case of
established contra-indications patients did not perform an X-ECG [16]. A non-Table 1
Baseline characteristics.
Overall
(n=756)
Lowa
(n=28
Age (years) 56±10 52±9
Women 369 (49%) 220 (7
Nicotine abuse 198 (26%) 49 (17
Hypertension 404 (53%) 141 (5
Diabetes mellitus 129 (17%) 27 (10
Dyslipidemia 451 (60%) 125 (4
Family history of cardiovascular disease 357 (47%) 146 (5
History of vascular disease 83 (11%) 22 (8%
Body-mass index 28±5 28±5
CCS performed 754 (100%) 284 (1
CTA performed 753 (100%) 284 (1
X-ECG performed 675 (89%) 259 (9
Inconclusive X-ECG 227 (30%) 72 (25
Catheter angiography 180 (24%) 24 (9%
Revascularisation 112 (15%) 11 (4%
PCI 87 (12%) 10 (4%
CABG 25 (3%) 1 (b1%
CCS= coronary calcium scanning, CTA= computed tomography angiography, X-ECG= exe
artery bypass graft surgery.
a Duke clinical score: pre-test probability of signiﬁcant CAD. Low: ≤30%; intermediate: 3
b ANOVA or nonparametric test.diagnostic result was deﬁned by discontinuation without evidence of myocardial
ischemia before reaching 85% of the target heart rate.
2.5. Coronary angiography
Clinically indicated quantitative coronary angiography (QCA) was performed using
standard techniques, with assessment of the most severe obstruction from ≥2
orthogonal projections using quantitative software (CAAS, Pie Medical, Maastricht, The
Netherlands).
2.6. Statistical analysis
Statistical analyses were performed using SPSS software (version 15.0, SPSS Inc,
Chicago, Ill). Categorical variables are presented as proportions. Continuous variables
are expressed as mean (±SD) or median (±IQR) as appropriate. All probability values
refer to 2-tailed tests of signiﬁcance; a probability valueb0.05 was considered
signiﬁcant. Differences between groups were compared using 2-sided unpaired t test,
chi-square test, or analysis of variance, as appropriate. Diagnostic performance
parameters in terms of sensitivity and speciﬁcity were calculated with 95% conﬁdence
intervals. Post-test probabilities were calculated for low, intermediate and high risk
patients using likelihood ratios.
Because of the known high number of not performed or inconclusive tests, we also
analyzed X-ECG results using an intention-to-diagnose approach, considering incon-
clusive tests as positive tests.
Additionally, we hypothesized that a calcium threshold slightly above the
conventional zero calcium would reduce the false positive results without signiﬁcant
sacriﬁce on the negative predictive value. A ROC analysis was performed to ﬁnd calcium
scores optimally discriminating angiographic obstructive CAD in our study population.4)
Intermediatea
(n=270)
Higha
(n=202)
P valueb
56±9 62±9 b0.001
8%) 122 (45%) 27 (13%) b0.001
%) 91 (34%) 58 (29%) b0.001
0%) 139 (52%) 124 (61%) 0.04
%) 49 (18%) 53 (26%) b0.001
4%) 187 (69%) 139 (69%) b0.001
1%) 138 (51%) 73 (36%) 0.001
) 27 (10%) 34 (17%) 0.04
27±5 28±5 0.63
00%) 268 (99%) 202 (100%) 0.25
00%) 268 (99%) 201 (100%) 0.39
1%) 241 (89%) 175 (87%) 0.22
%) 90 (33%) 65 (32%) 0.06
) 69 (26%) 87 (43%) b0.001
) 32 (12%) 69 (34%) b0.001
) 26 (10%) 51 (25%) b0.001
) 6 (2%) 18 (9%) b0.001
rcise electrocardiography, PCI = percutaneous coronary intervention, CABG= coronary
0–70%; high: N70%.
Fig. 1. Distribution of groups with no detectable calcium, intermediate calcium scores
and high calcium scores considering pre-test probability of CAD. Fig. 3. Distribution of exercise electrocardiography results considering pre-test
probability of CAD.
Table 3
Operating characteristics.
Sensitivity
% (95% CI)
Speciﬁcity
% (95% CI)
LR+
(95% CI)
LR−
(95% CI)
Overall
CCS (N0) 95 (91–98) 50 (45–54) 1.9 (1.7–2.1) 0.1 (0.05–0.2)
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3.1. Coronary calcium scanning
In two patients CCS was not performed because of patient
preference or severe obesity. There was no detectable coronary
calcium in 281/756 (37%) patients, 152 (54%) in the low, 99 (37%) in
the intermediate and 30 (15%) in the high risk group (Fig. 1).
Angiographic obstructive CADwas found in 10/281 (4%) patients with
no calcium, 2/152 (1%) with low risk, 4/99 (4%) with intermediate risk
and 4/30 (13%) with high risk. In comparison, these patients did not
differ in age (55 vs. 56 years, p=0.67), gender (30 vs. 49%, p=0.21),
smoking (30 vs. 26% p=0.75), hypertension (50 vs. 54% p=0.82),
dyslipidemia (60 vs. 59% p=0.94), family history (60 vs. 47%
p=0.41) or BMI (27 vs. 28 p=0.66). However, none had a prior
history of vascular disease or diabetes mellitus.
A ROC analysis with consideration for pre-test probability of CAD
revealed calcium thresholds of 2, 2.5 and 15 Agatston units in low,
intermediate and high risk group, respectively, to optimally differen-
tiate patients with or without obstructive CAD (Fig. 2).
3.2. Exercise electrocardiography
In 81 (11%) patients X-ECG could not be performed because of
inability to cycle, resting ECG abnormalities, pulmonary disease andFig. 2. ROC-curve of coronary calcium scores predicting obstructive coronary disease
considering pre-test probabilities.combined or unspeciﬁed reasons. In 227 (30%) patients X-ECG did not
yield a diagnostic result, mostly because the target heart rate was not
reached. A normal X-ECG was found in 319/756 (42%) patients, 157
(49%) in the low, 109 (34%) in the intermediate and 53 (17%) in the
high risk group (Fig. 3). A normal X-ECG was found in 55/319 (17%)
patients with angiographic obstructive CAD, 15/157 (10%) with low
risk, 17/109 (16%) with intermediate risk and 23/53 (43%) with high
risk.3.3. Coronary angiography
Invasive coronary angiography was performed in 180 patients
(24%), with subsequent need for coronary revascularisation in 112
(15%) patients: 87 (12%) percutaneous coronary intervention, 25 (3%)
coronary bypass surgery.Optimal CCS 94 (89–96) 58 (54–63) 2.3 (2.0–2.5) 0.1 (0.06–0.2)
X-ECG 56 (47–65) 82 (77–86) 3.1 (2.4–4.1) 0.5 (0.4–0.7)
X-ECG-itd 70 (63–76) 54 (49–58) 1.5 (1.3–1.7) 0.6 (0.5–0.7)
Low
CCS (N0) 94 (78–99) 60 (53–66) 2.3 (1.9–2.8) 0.1 (0.03–0.4)
Optimal CCS 94 (78–99) 68 (62–74) 2.9 (2.4–3.6) 0.1 (0.02–0.3)
X-ECG 21 (7–46) 85 (78–89) 1.4 (0.5–3.5) 0.9 (0.7–1.2)
X-ECG-itd 44 (26–64) 61 (55–67) 1.1 (0.7–1.8) 0.9 (0.6–1.3)
Intermediate
CCS (N0) 94 (84–98) 47 (40–54) 1.8 (1.5–2.0) 0.1 (0.05–0.3)
Optimal CCS 94 (84–98) 52 (45–59) 2.0 (1.7–2.3) 0.1 (0.02–0.3)
X-ECG 55 (38–71) 81 (73–88) 3.0 (1.8–4.8) 0.5 (0.4–0.8)
X-ECG-itd 73 (60–83) 51 (44–59) 1.5 (1.2–1.9) 0.5 (0.4–0.8)
High
CCS (N0) 96 (90–99) 29 (20–39) 1.3 (1.2–1.5) 0.1 (0.05–0.3)
Optimal CCS 94 (87–97) 46 (36–57) 1.7 (1.4–2.1) 0.1 (0.06–0.3)
X-ECG 67 (54–77) 73 (57–85) 2.5 (1.5–4.2) 0.5 (0.3–0.6)
X-ECG-itd 76 (65–84) 37 (27–49) 1.2 (1.0–1.5) 0.7 (0.4–1.0)
CCS = coronary calcium scanning, Optimal CCS = ROC-based calcium thresholds,
X-ECG= exercise electrocardiography, X-ECG-itd = exercise electrocardiography with
an intention-to-diagnose approach, LR+=positive likelihood ratio, LR−=negative
likelihood ratio.
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Overall CCS showed signiﬁcantly higher negative predictive value
compared to X-ECG, 96% (95% CI 93–98) vs. 83% (95% CI 78–87),
regardless of pre-test probability of disease. In patients with low and
intermediate risk we found excellent negative predictive values of
99% (95–100) and 96% (89–99), respectively (Table 3). No detectable
calcium was associated with a likelihood ratio of 0.11 (0.03–0.4), 0.13
(0.05–0.3) and 0.13 (0.05–0.3) in the low, intermediate and high riskFig. 4. 52 year old female with typical angina pectoris, positive family history and recent ces
CTA curved MPR and volume rendering show a non-obstructive, non calciﬁed plaque in th
obstructions. D: Optical Coherence Tomography (OCT) (Lightlab Imagewire®, Lightlab Ima
plaque in the LAD. The eccentric intimal thickening is visible from 12–6 o'clock. The 3-laye
corresponds with the intima, the dark middle layer corresponds with the media and the out
slight ST-deviation of ±1 mm in V4-V6.group. A normal XECG was associated with a likelihood ratio of 0.93
(0.7–1.2), 0.55 (0.4–0.8) and 0.46 (0.3–0.6) in the low, intermediate
and high risk group, respectively.
By increasing the calcium threshold to 2, 2.5 and 15 Agatston units,
respectively, based on the previous ROC analysis, the speciﬁcity of CCS
increased from 60% (53–66), 47% (40–54) and 29% (20–39) to 68%
(62–74), 52% (45–59) and 46% (36–57) in the low, intermediate and
high risk group, respectively (Table 3). Excluding non-diagnostic
results, X-ECGwas signiﬁcantly more speciﬁc: overall 82% (77–86) vs.sation of smoking. A, B: There was no detectable calcium on the non-enhanced CT-scan.
e mid left anterior descending (LAD) coronary artery. C: CAG revealed no signiﬁcant
ging, Westford, MA, USA) conﬁrmed the presence of a non-obstructive, non calciﬁed
red appearance of the vessel is well visible: the inner endoluminal yellow, bright layer
er, bright layer corresponds with the adventitia. E: X-ECG was borderline positive with
194 A. Dedic et al. / International Journal of Cardiology 163 (2013) 190–19550% (45–54), regardless of pre-test probabilities. However, using an
intention-to diagnose approach, assuming non-diagnostic tests to be
positive, the speciﬁcity decreased to a value comparable to CCS.
4. Discussion
From our results we concluded that the absence of calcium rules
out angiographic obstructive CAD reliably in real-world patients,
particularly in those with low to intermediate risk of CAD, out-
performing X-ECG in this setting. No calcium was found in 281/756
(37%) patients and 319/756 (42%) patients had a normal X-ECG result.
Patients without detectable calcium were substantially less likely to
have obstructive CAD (Fig. 4) in comparison to a normal X-ECG result:
10 (4%) vs. 55 (17%) (pb0.001).
5. Clinical implications
Recently a large US registry reported on the low yield of
obstructive coronary artery disease by invasive coronary angiography,
recommending a more effective non-invasive diagnostic workup [17].
While CCS has been used for exclusion of CAD in asymptomatic and
symptomatic individuals for the past decade [15,18], its capacity to
rule out obstructive CAD was recently questioned in a paper assessing
patients referred for invasive catheterisation [19]. According to the
Bayes' theorem test performance is inﬂuenced by the pre-test
probability of the population. Patients selectively referred for
catheterization generally have a higher likelihood of obstructive
CAD compared to our outpatient cohort presenting with stable chest
pain. Our results demonstrate that the negative predictive value of the
calcium scan is excellent in subgroups with low disease prevalence. In
line with the observations by Gottlieb et al., the rate of patients with
obstructive CAD and no detectable calcium gradually increases
concomitantly with their pre-test probability.
In low risk patients (0–30%) a negative calcium score reduced the
likelihood of obstructive CAD b5% (Fig. 5), removing the need for
further diagnostic work-up in a substantial proportion of patients
(19%). For intermediate risk patients (30–70%) the likelihood
decreased to 5–25%, reducing the need for further testing, particularly
in those with a post-test probability of b10%. In high risk patients
(N70%) neither CCS nor X-ECG excluded angiographic obstructiveFig. 5. Post test probability of obstructive coronary artery disease (CAD) considering
pre-test probability. Conventional CCS = coronary calcium scanning regarding zero
calcium as negative result, exercise electrocardiography, optimal CCS = coronary
calcium scanning with ROC analysis based thresholds, XECG = exercise electrocardi-
ography, XECG-itd = exercise electrocardiography with an intention-to-diagnose
approach.CAD, although a negative X-ECG may be more helpful to exclude
hemodynamically relevant lesions and guide patient management.
Furthermore, we found that a cut-off value above the conventional
zero calcium score reduced false positive results without sacriﬁce on
the high negative predictive value in patients with a low to
intermediate probability.6. Limitations
Because not all patients had a clinical indication for invasive
angiography, a composite diagnostic endpoint including CT angiog-
raphy was used. Given the well established diagnostic accuracy of
CTA, especially its negative predictive value, performing invasive CAG
in every patients would be unethical [20]. However, limiting the study
to patients with QCA would have resulted in loss of the real-world
character of this study. In this study we focused on reliability of CCS or
X-ECG to rule out CAD. We believe that using a composite endpoint of
CTA next to invasive angiography does not jeopardize our conclusions.
Nevertheless to anticipate overestimation of CTA we performed a
sensitivity analysis using a composite diagnostic endpoint of N50%
coronary stenosis by CAG (overruling any CTA result) and N50% left
main or three-vessel disease or N70% one or two-vessel stenosis by
CTA. By excluding patients with intermediate coronary stenosis on
one or two vessels, we obtained no signiﬁcantly different diagnostic
performances of CCS and X-ECG.
There was no comparison of CCS to more advanced functional
imaging tests, nor was the hemodynamic signiﬁcance of the coronary
lesions routinely determined. Assessment of myocardial ischemia has
prognostic consequences and is important for clinical decision
making. The incremental value of stress testing applies mostly to
those with angiographic coronary disease, and less to patients in
whom CAD has been excluded (by CTA or QCA), which involves the
majority of patients presenting in a chest pain clinic. Recent work
from Esteves et al. demonstrated that the absence of coronary calcium
also excludes ischemia on functional testing [21]. In addition, patients
with no detectable calcium show slow progression of CAD over
time [22].
Nevertheless, clinical outcome studies are needed to evaluate the
value of CCS as a tool for exclusion of obstructive CAD, in comparison
to functional tests.7. Conclusions
Coronary calcium scanning is a reliable initial test in real-world
patients with stable chest pain to rule out obstructive CAD and it can
be performed in virtually all patients. In low risk patients without
detectable coronary calcium further diagnostic work-up seems
redundant as the post-test probability of obstructive CAD is less
than 5% for these patients. In the group of patient with intermediate
risk of obstructive CAD the likelihood decreased to 5–25% after a
negative CCS, reducing the need for further testing, particularly in
those with a post-test probability of b10%. High risk patients do not
seem to beneﬁt from neither CCS nor X-ECG to exclude angiographic
obstructive CAD, although a normal X-ECG may be more helpful to
exclude hemodynamically relevant lesions and guide management.Acknowledgment
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